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THE carcinogenic properties ofiron macromolecular complexes in rats and mice
were described in 1959 and the early 1960's (Richmond, 1959; Haddow and
Horning, 1960; Baker et al., 1961; Lundin, 1961; Fielding, 1962). Since that
time, a number of iron-containing compounds have been tested and found to
induce subcutaneous tumours in various experimental animals (see Roe, 1967).
In the course of a general survey of the carcinogenicity of iron-containing com-
pounds, 2 further substances-ferric sodium gluconate and iron dextran glycerol
glycoside-have emerged as agents with definite carcinogenic activity in rats and
mice.
FERRIC SODIUM GLUCONATE COMPLEX
Materials and Methods
Forty male CB stock mice, aged 11 weeks, were used. The animals were
housed in metal cages in groups of 5 and maintained on cubed diet No. 86 (Messrs.
Dixon, Ware, Herts.) and water ad libitum.
Ferric sodium gluconate complex was obtained from Dr. Kutiak and Co.,
Arzneimittelfabrik, Vienna. It was supplied in 2 ml. ampoules, each of which
contained 150 mg. iron. Tests were carried out on Batch No. 22 01 11.
Twenty animals received 17 weekly subcutaneous injections of ferric sodium
gluconate in the right flank-0'1 ml. for the first 3 weeks and 0.05 ml. for the
following 14 weeks. The total amount of iron injected was 75 mg. Twenty
untreated mice served as controls.
The animals were examined daily. Sick mice were killed and the survivors
were killed 16 to 18 months after the beginning of the experiment. Complete
post-mortem examinations were carried out and tissues showing macroscopic
abnormalities were fixed in Bouin's solution. Paraffin sections 5 ,u thick were
prepared and stained with haematoxylin and eosin.
RESULTS
The survival ofmice in the test and control groups, together with the incidence
of local and distant tumours, is shown in Table I. Injection-site tumours devel-
oped in 5 test animals-the first after 10 months and the last after 15 months.
Once palpable, they grew rapidly and it was necessary to kill the mice within 30
days of the first appearance of a definite subcutaneous mass. The morphology
ofthese neoplasms was similar to that reported previously in animals injected with
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showing variable degrees of differentiation. A few iron-containing macrophages
werepresentin andaroundthe tumours butno iron-pigment was seenin the tumour
cells themselves. No metastases were found. Two ofthe sarcomas were success-
fully transplanted into other mice of the same stock strain.
The injection sites in mice which did not develop local tumours showed the
usual changes associated with prolonged parenteral administration of iron. The
flanks were thickened, indurated, and hairless. The subcutaneous tissues were
stained brown and contained large numbers of macrophages laden with iron.
Multinucleate giant cells were sometimes seen, together with a few chronic
inflammatory cells. Fibrous tissue was increased in all animals.
The number and distribution of distant neoplasms in the test mice were low
(Table I). Malignant lumphomas were found in 2 animals, one of which also
developed an injection-site sarcoma.
TABLE I.-Induction ofTumours in Mice by Ferric Sodium Gluconate
Age (months)
Test animals . 3 6 9 12 15 18
Survivors . 20 20 19 18 14 0
Tumours (cumulative totals)
Injection-site . 0 0 0 2 4 5
Other . 0 0 0 0 0 2*
Control animals
Survivors . 20 11 8 5 3 0
Tumours . 0 0 0 1* 2* 5*
* All malignant lymphomas
Various non-malignant changes were commonly encountered in other tissues.
Increased amounts of iron-pigment were seen in macrophages in the axillary
and inguinal lymph nodes, spleen and pancreas and in hepatic Kupffer cells.
Fatty change and necrosis were sometimes observed in hepatocytes but this was
not apparently related to the amount ofiron present in the liver. Slight atrophy
of pancreatic acinar cells, bronchiectasis, and bronchopneumonia were also seen
in some animals.
Five untreated mice from the control group developed malignant lymphomas.
No other tumours were seen and the incidence of non-malignant changes such as
hepatic degeneration and pulmonary infection was similar to that found among
the test animals.
IRON DEXTRAN GLYCEROL GLYCOSIDE
Materials and Methods
One hundred and five male CB stock mice were divided into 3 test groups and
1 untreated control group. The animals were aged 11 weeks and maintained as
in the previous experiment. In addition, 48 male CB stock rats were used.
These animals were 8 weeks old and were housed in metal cages, 4 in each; they
were fed cubed diet No. 86 and water ad libitum.
Iron dextran glycerol glycoside was obtained from Dr. P. G. Marshall, The
Nicholas Research Institute, Slough, Bucks. It was supplied in ampoules con-
taining 50 mg. iron/ml. Tests were carried out on Batch numbers A 2533 and
0 3214.
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The test animals received subcutaneous injections of iron dextran glycerol
glycoside into the right flank according to the scheme shown in Table II:
TABLE II.-Treatment of Mice and Rats with Iron Dextran Glycerol Glycoside
Total amount
Dose per of iron
injection administered
No. of animals No. of injections (ml.) (mg.)
Mice
Group 1 20 . 5, weekly 01 . 25
Group 2 25 . 8, weekly . 0-2 80
Group 3 20 . 29, fortnightly . 0-05 . 75
Group 4 40 Uninjected controls
Rats
Group 1 24 . 25, weekly . 05 . 625
Group 2 24 . Uninjected controls
The subsequent care of the animals, the post-mortem examinations, and the
selection and staining of tissues for histological examination were as described
previously.
Results
Effects in mice.-Although 52 mice in the 3 test groups lived for more than 12
months after the beginning of the experiment, only one developed a sarcoma at
the site ofinjection, a tumour which appeared after 11 months in an animal from
Group 2. The injection sites in the remaining 104 mice showed the usual changes
associated with repeated subcutaneous injections of iron compounds.
The incidence of distant tumours was high in both test and control groups.
Malignant lymphomas, including thymomas, were the commonest lesions, followed
by hepatomas and pulmonary adenomas. One mouse from Group 1 developed
a squamous carcinoma of the forestomach with metastasis to the omental fat,
mesentery and diaphragm.
Non-neoplastic changes in distant tissues consisted ofdeposits ofiron-pigment
in macrophages in the liver, spleen, pancreas and occasionally the kidneys of
mice injected with the iron compound. Test and control animals showed fatty
change and patchy necrosis of hepatic parenchyma and pulmonary infection.
Effects in rats.-The survival of test and control rats, together with the
incidence of injection-site sarcomas, is recorded in Table III. Among the test
TABLE III.-Induction ofTumours in Rats with Iron Dextran Glycerol Glycoside
Age (months)
Test animals 3 6 9 12 15 18 21 24 27
Survivors . 24 24 24 22 18 10 5 2 0
Tumours (cumulative totals)
Injection-site 0 0 0 0 2 4 8 10 12
Other .0 0 0 0 la 3b,c 3 3 3
Control animals
Survivors 24 24 22 21 11 8 5 4 0
Tumours (cumulative totals) .0 0 0 0 Id 2e 3t 3 3
a - mammary carcinoma d = hepatoma
b mammary fibroadenoma e = malignant lymphoma
c= solitary exocrine adenoma of pancreas t= subcutaneous fibroma
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animals, 12 developed local tumours, the first after 13 months and the last after
25 months. They grew rapidly and the animals were killed 20 to 30 days after
the lesions were first observed. Of the 12 neoplasms seen, 10 were pleomorphic
or spindle cell sarcomas, similar inhistological appearance to those which developed
in mice injected with ferric sodium gluconate. There were also 2 fibromas. No
metastases were observed.
The incidence ofdistant neoplasms among the test animals was low (Table III).
Of the 3 tumours found, only one-a solitary exocrine adenoma of the pancreas
-was seen in an animal which already had an injection site sarcoma. The
non-malignant changes in distant tissues were similar to those described in mice
injected with iron dextran glycerol glycoside except that there was more morpho-
logical evidence of accumulations of iron in tissues such as the spleen, liver and
pancreas.
Three tumours were found among the untreated control rats-a mammary
fibroadenoma, a mammary carcinoma and a subcutaneous fibroma from the
occipital region.
DISCUSSION
It is clear that repeated subcutaneous injections of ferric sodium gluconate
induce local sarcomas in mice and that iron dextran glycerol glycoside, adminis-
tered in a similar fashion, induces injection-site tumours in rats. In both
instances, the animals received doses of iron which were large in relation to their
body weight but the part played by iron-overloading (cf. Golberg et al., 1960)
in tumour induction by these 2 compounds cannot be assessed. The difficulty is
emphasised by the observation that while ferric sodium gluconate induced a
number ofinjection-site sarcomas in mice, iron dextran glycerol glycoside (even in
large and prolonged doses) showed negligible carcinogenic activity in the same
species. Another feature is the apparent difference in carcinogenic potency of
iron dextran glycerol glycoside in rats and mice. Although the total amount of
iron administered to the mice was higher, on a body weight basis, than that given
to the rats, the carcinogenic response was strikingly less. In previous investiga-
tions on macromolecular iron complexes, the response of the 2 species has usually
been broadly similar.
Since different dose-schedules were used in the 2 experiments, it is not possible
to compare the sarcomas induced in mice with ferric sodium gluconate, and in
rats with iron dextran glycerol glycoside, in terms oftheir final incidence and times
of induction. Histologically, however, the sarcomas were similar in the 2 groups
and resembled the tumours induced by other iron-containing compounds; such
lesions have frequently been described and illustrated in previous papers. One
difference between rats and mice which emerged from the present study was the
tendency for rats-but not mice-to develop injection-site fibromas. Fibromas
are not uncommon in rats injected with macromolecular iron complexes (e.g.
Roe et al., 1964; Roe and Carter, 1967) but we have not seen such tumours in
mice, nor are they described in other accounts dealing with the carcinogenicity of
iron-compounds in mice. If this apparent species difference is a valid one, it
suggests that the final neoplastic response ofthe subcutaneous tissues to repeated
injections of iron-containing substances may be significantly different in rats and
mice. Differences between rats and mice in terms of the amount of iron retained
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at injection sites have been reported (Golberg et al., 1960; Baker et al., 1960) but
differences in the type of tumour produced have not been noted previously.
It is still uncertain whether iron-containing compounds are likely to induce
an increase in the incidence and variety of neoplasms in tissues distant from the
site of injection (Roe and Carter, 1967). But in the present study, the incidence
of distant tumours in mice treated with ferric sodium gluconate, and in rats
treated with iron dextran glycerol glycoside, was unusually low. Distant tumours
were more numerous in mice injected with iron dextran glycerol glycoside but,
as emphasised earlier, a high incidence ofneoplasms was also found in the corres-
ponding group of untreated control animals. One of the tumours encountered
in a test mouse-the locally-metastasising squamous carcinoma ofthe forestomach
-is certainly a rarity (Rowlatt, 1967) but its relationship to treatment with iron
dextran glycerol glycoside is obscure.
The present findings provide more information on the carcinogenicity of iron-
containing compounds in rats and mice but they do nothing towards resolving
the controversy concerning the carcinogenic hazards of such compounds in man
(Haddow and Horning, 1960; Baker et al., 1961; Haddow et al., 1964; Roe, 1966).
As Haddow and his colleagues have stressed, it is still doubtful whether parenteral
iron preparations have been used in clinical practice for a sufficient period oftime
to be certain that such materials are not carcinogenic. The therapeutic value of
iron-containing compounids is beyond dispute but, at the present time, it seems
reasonable to urge caution in the selection of patients and duration of treatment
and to avoid the indiscriminate use of such substances.
SUMMARY
Five out of 20 mice which received 17 once-weekly subcutaneous injections
of ferric sodium gluconate (total 1 ml.) developed spindle cell or pleomorphic
sarcomas at the injection site.
Ten out of24ratswhichreceived 25 once-weeklyinjections of05 ml. ofanother
proprietary preparation-iron dextran glycerol glycoside-also developed local
sarcomas; in addition, 2 developed local fibromas. Of 104 mice given 5 injections
of0.1 ml., 8 injections of0-2 ml. or 29 injections of0 05 ml. ofthe same preparation,
only 1 developed a neoplasm at the site ofinjection.
Differences between mice and rats in their response to injected iron compounds
are discussed and the apparent rarity oflocal fibromas in mice is emphasised.
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